FIRST DIAGNOSIS OF UVEITIS IS NOT HIGHER AMONG JUVENILE IDIOPATHIC ARTHRITIS (JIA) PATIENTS RECEIVING ETANERCEPT COMPARED TO METHOTREXATE

被引：0
|
作者：
Davies, R. [1 ]
De Cock, D. [1 ]
Kearsley-Fleet, L. [1 ]
Ramanan, A. [2 ,3 ]
Hyrich, K. L. [1 ,4 ]
机构：
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Univ Hosp Bristol NHS Fdn Trust, Pediat Rheumatol, Bristol, Avon, England
[3] Univ Bristol, Sch Clin Sci, Ophthalmol, Bristol, Avon, England
[4] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res Manchester Musculoskeletal Bio, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5211
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0351
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [31] REAL-WORLD EFFECTIVENESS OF ETANERCEPT AND ADALIMUMAB IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITHOUT UVEITIS
    Kearsley-Fleet, L.
    Baildam, E.
    Beresford, M.
    Foster, H.
    Southwood, T.
    Thomson, W.
    Hyrich, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 927 - 927
  • [32] SAFETY PROFILE OF ETANERCEPT IN LONG-TERM USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, Jens
    Klein, Ariane
    Niewerth, Martina
    Ganser, Gerd
    Aries, Peer
    Walther, Marisa
    Haas, Peter
    Keysser, Gernot
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 102 - 102
  • [33] Cytokine Profiles at Diagnosis of Juvenile Idiopathic Arthritis (JIA)
    Yeung, Rae
    Benseler, Susanne
    Oen, Kiem
    Tucker, Lori
    Duffy, Ciaran
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2583 - 2583
  • [34] Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
    EM Baildam
    S Saladi
    Pediatric Rheumatology, 6 (Suppl 1)
  • [35] Uveitis Screening in Juvenile Idiopathic Arthritis (JIA): A Quality Improvement Project
    Ho, Meghan
    Tse, Shirley
    Saurenmann, Traudel
    Sheikh, Shehla
    Wasylciw, Melitta
    Benseler, Susanne
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1143 - 1143
  • [36] Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy
    Lahdenne, P
    Rapola, J
    Ylijoki, H
    Haapasaari, J
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (11) : 2442 - 2445
  • [37] Therapy Survival and Long-Term Safety of Etanercept in Patients with juvenile idiopathic Arthritis (JIA)
    Klotsche, J.
    Niewerth, M.
    Weber, K.
    Hammer, M.
    Haas, J.
    Horneff, G.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 92 - 93
  • [38] No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis – a matched pair analysis
    Heinrike Schmeling
    Gerd Horneff
    Pediatric Rheumatology, 10 (Suppl 1)
  • [39] An observational post approval safety study of etanercept and methotrexate in treatment of juvenile idiopathic arthritis (JIA) using the German biologics JIA registry (BIKER)
    MacDonald, Sarah
    Borlenghi, Cecilia E.
    Vlahos, Bonnie
    Chen, Yan
    Klein, Ariane
    Horneff, Gerd
    Koram, Nana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 137 - 138
  • [40] Combination of cyclosporine a and methotrexate in children with refractory juvenile idiopathic arthritis (JIA)
    Alexeieva, Y. I.
    Valieva, S. I.
    Bzarova, T. M.
    Afonina, E. Y.
    Apaeva, D. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 335 - 335
12345